Investing Profile

Christoph Massner

InvestorVC
Partner at Earlybird Venture Capital
earlybird.com/team/Berlin, Germany
Photo of Christoph Massner, Partner at Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Melbourne Network
25 CONNECTIONS
Earlybird Venture Capital Network
22 CONNECTIONS
Earlybird Venture Capital Network
22 CONNECTIONS
Earlybird Venture Capital Network
22 CONNECTIONS
Earlybird Venture Capital Network
22 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
€350m
CompanyStageDateRound SizeTotal Raised
Hilo
Series BMay 2025$42M
$100M
Co-investors: Michael Sidler (Redalpine Venture Partners), Inga Deakin (Molten Ventures), Christian Wenger
Ariceum Therapeutics
Series AApr 2023$25M
$52M
Co-investors: Olivier Litzka (Andera Partners), Per Samuelsson (HealthCap)
Partner Earlybird Venture CapitalPresent
Member Board of Directors Hilo by AktiiaPresent
Member Board of Directors NoscendoPresent
Board Observer Shape Memory Medical Inc.Present
Member Board of Directors Ariceum TherapeuticsPresent
Board Observer Alesi Surgical LtdPresent
Principal Earlybird Venture CapitalPresent
Member Board of Directors MaviePresent
Associate Earlybird Venture CapitalPresent
Analyst Earlybird Venture CapitalPresent
Co-Founder and CEO Wermon GmbHPresent
Sales Representative TaylorMade Golf CompanyPresent
University of Melbourne Research Project Structural Biology
University of Stuttgart Diplom Biologe t.o. Technical Biology
Technische Universität München Doctor of Philosophy - PhD Synthetic Biology
Technische Universität München Doctor of Philosophy - PhD Synthetic Biology
Technical University of Munich Doctor of Philosophy - PhD Synthetic Biology
Technical University of Munich Doctor of Philosophy - PhD Synthetic Biology